Capsule Summary Slidesets

Share

Program Content

Activities

  • REACH: Hydroxyurea for SCA
    REACH: Long-term Analysis of Dose-Optimized Hydroxyurea for Treatment of Pediatric Patients With Sickle Cell Anemia in Sub-Saharan Africa
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2023

  • Lovo-cel in SCD Pooled Analysis
    Pooled Analysis of Phase I/II and Phase III Trials of Lovotibeglogene Autotemcel Gene Therapy in Patients With Sickle Cell Disease
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 13, 2023

  • BMT CTN 1507 RIC BMT SCD
    BMT CTN 1507: Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults With Severe Sickle Cell Disease
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2023

  • APPLY-PNH Final Results
    APPLY-PNH Final 48-Wk Results: Phase III Trial of Iptacopan Monotherapy in Patients With PNH and Residual Anemia With Anti-C5 Therapy
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2023

  • Sutimlimab in CAD Safety Analysis
    Pooled Post Hoc Analysis of Safety Outcomes From Phase III CARDINAL and CADENZA Trials of Sutimlimab in Cold Agglutinin Disease
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2023

  • PNH ALPHA Study
    ALPHA: Phase III Long-term Data for Ravulizumab or Eculizumab With Add-on Danicopan or Placebo in Patients With PNH and cs-EVH
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc., AstraZeneca, Daiichi Sankyo, Inc., Merck Sharp & Dohme LLC, Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc, and Seagen Inc.

AbbVie Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Regeneron Pharmaceuticals, Inc

Seagen Inc.